← Leaderboards
Szu-Wen Wang
University Of California-Irvine
$2,953,408
Attributed
$2,953,408
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $338.6K · FY2010–24$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,953,408 · 5
By mechanism
R21$1,609,089 · 4
R01$1,344,319 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California-Irvine
Same institution · by research overlap
- Rachel Martin$2,243,080
- Douglas J Tobias$6,492,355
- Michael B Dennin$1,819,066
- Thomas J Koob$351,499
- Rachel Wagner Martin$4,170,663
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsDesignProteinsResponseMalignant NeoplasmsNanoparticleImmune ResponseIn VivoIn VitroImmuneAntigensMediatingVaccinesAdjuvantEpitopesCancer CellBaseVaccine DevelopmentImmune SystemDendritic CellsOvalbuminPropertyCancer TherapyImmunotherapy
Grant awards (12)
Improving the Immune Response to Nanoparticle-Based SARS-CoV-2 Vaccines$196,250
R21 · FY2024 · AI · contact PI
Improving the Immune Response to Nanoparticle-Based SARS-CoV-2 Vaccines$235,500
R21 · FY2023 · AI · contact PI
Tumor-Associated Antigen Delivery using Protein Nanoparticles for Combined Immunotherapy$336,889
R01 · FY2022 · EB · contact PI
Tumor-Associated Antigen Delivery using Protein Nanoparticles for Combined Immunotherapy$330,747
R01 · FY2021 · EB · contact PI
Tumor-Associated Antigen Delivery using Protein Nanoparticles for Combined Immunotherapy$338,071
R01 · FY2020 · EB · contact PI
Tumor-Associated Antigen Delivery using Protein Nanoparticles for Combined Immunotherapy$338,612
R01 · FY2019 · EB · contact PI
Modulation of Immune Responses to Implanted Surfaces Using Engineered ECM Domains$193,125
R21 · FY2018 · EB · contact PI
Modulation of Immune Responses to Implanted Surfaces Using Engineered ECM Domains$228,573
R21 · FY2017 · EB · contact PI
Nanoparticle-Modulated Response Against Tumor-Associated Antigens$177,249
R21 · FY2015 · EB · contact PI
Nanoparticle-Modulated Response Against Tumor-Associated Antigens$203,148
R21 · FY2014 · EB · contact PI
Multifunctional Protein Nanocapsules for Targeted Delivery$176,165
R21 · FY2011 · EB · contact PI
Multifunctional Protein Nanocapsules for Targeted Delivery$199,079
R21 · FY2010 · EB · contact PI